- Home
- OUST vs ABCL Comparison
OUST vs ABCL Comparison
Compare OUST & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OUST
- ABCL
- Stock Information
- Founded
- OUST 2015
- ABCL 2012
- Country
- OUST United States
- ABCL Canada
- Employees
- OUST N/A
- ABCL N/A
- Industry
- OUST Industrial Machinery/Components
- ABCL Biotechnology: Pharmaceutical Preparations
- Sector
- OUST Technology
- ABCL Health Care
- Exchange
- OUST Nasdaq
- ABCL Nasdaq
- Market Cap
- OUST 1.1B
- ABCL 1.1B
- IPO Year
- OUST N/A
- ABCL 2020
- Fundamental
- Price
- OUST $30.65
- ABCL $4.39
- Analyst Decision
- OUST Strong Buy
- ABCL Strong Buy
- Analyst Count
- OUST 7
- ABCL 5
- Target Price
- OUST $22.00
- ABCL $8.00
- AVG Volume (30 Days)
- OUST 2.9M
- ABCL 5.5M
- Earning Date
- OUST 08-07-2025
- ABCL 08-07-2025
- Dividend Yield
- OUST N/A
- ABCL N/A
- EPS Growth
- OUST N/A
- ABCL N/A
- EPS
- OUST N/A
- ABCL N/A
- Revenue
- OUST $125,848,000.00
- ABCL $32,875,999.00
- Revenue This Year
- OUST $32.34
- ABCL N/A
- Revenue Next Year
- OUST $36.11
- ABCL $71.11
- P/E Ratio
- OUST N/A
- ABCL N/A
- Revenue Growth
- OUST 26.37
- ABCL N/A
- 52 Week Low
- OUST $5.84
- ABCL $1.89
- 52 Week High
- OUST $36.25
- ABCL $5.82
- Technical
- Relative Strength Index (RSI)
- OUST 58.35
- ABCL 51.44
- Support Level
- OUST $27.78
- ABCL $4.01
- Resistance Level
- OUST $36.25
- ABCL $4.81
- Average True Range (ATR)
- OUST 3.00
- ABCL 0.36
- MACD
- OUST 0.08
- ABCL -0.05
- Stochastic Oscillator
- OUST 59.30
- ABCL 42.59
About OUST Ouster Inc.
Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and Pacific, Europe, Middle East, and Africa regions. It derives maximum revenue from Americas.
About ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.